开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
AT CLOSE, SHANGHAI COMPOSITE INDEX DOWN 0.74%, SHENZHEN COMPONENT INDEX DOWN 1.6%, CSI 300 INDEX DOWN 1.04%, CHINEXT INDEX DOWN 2.31%
2026-04-02
AT CLOSE, SHANGHAI COMPOSITE INDEX DOWN 0.74%, SHENZHEN COMPONENT INDEX DOWN 1.6%, CSI 300 INDEX DOWN 1.04%, CHINEXT INDEX DOWN 2.31%
返回
其他消息
2026-04-02
The Trump administration is preparing to impose tariffs of up to 100% on certain imported medicines, potentially as soon as Thursday, targeting companies that have not agreed to boost US manufacturing, according to people familiar with the matter. The move follows earlier threats to penalize branded drug imports and is based on a national security probe under Section 232 of the Trade Expansion Act. Firms including Pfizer, AstraZeneca and Novo Nordisk have reached agreements to invest in the US a
The Trump administration is preparing to impose tariffs of up to 100% on certain imported medicines, potentially as soon as Thursday, targeting companies that have not agreed to boost US manufacturing, according to people familiar with the matter. The move follows earlier threats to penalize branded drug imports and is based on a national security probe under Section 232 of the Trade Expansion Act. Firms including Pfizer, AstraZeneca and Novo Nordisk have reached agreements to invest in the US and cut prices in exchange for tariff relief, while countries with trade deals may face lower, capped duties.
2026-04-02
印度卢比创下自2013年9月以来的最佳单日涨幅。美元兑印度卢比USD/INR收报93.10,日内跌1.8%。
印度卢比创下自2013年9月以来的最佳单日涨幅。美元兑印度卢比USD/INR收报93.10,日内跌1.8%。
Chat with us
, powered by
LiveChat